Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
European Heart Journal. Case Reports
|
December 31, 2024
A rare cardiac presentation of a lymphoma: case report
Ilona Grohs, Katharina Riedl, Christa Kliment, et al.
Multiple Sclerosis and Related Disorders
|
May 31, 2022
Has the pandemic changed treatment strategy in multiple sclerosis?
Gabriel Bsteh, Katharina Riedl, Nik Krajnc, et al.
Frontiers in Neurology
|
March 24, 2022
Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
Nik Krajnc, Patrick Altmann, Katharina Riedl, et al.
Frontiers in Neurology
|
February 3, 2022
Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score
Gabriel Bsteh, Harald Hegen, Katharina Riedl, et al.
Multiple Sclerosis and Related Disorders
|
April 27, 2022
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication - a retrospective multicentre study
Franziska Di Pauli, Katharina Riedl, Harald Hegen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 2, 2022
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis
Klaus Berek, Harald Hegen, Jakob Hocher, et al.
Neurology
|
August 2, 2022
Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis
Gabriel Bsteh, Nik Krajnc, Katharina Riedl, et al.
European Journal of Neurology
|
November 27, 2024
Autoimmune screening panel in patients with multiple sclerosis: A Vienna multiple sclerosis database study
Fabian Föttinger, Nik Krajnc, Katharina Riedl, et al.
Multiple Sclerosis and Related Disorders
|
July 7, 2022
Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study
Nik Krajnc, Harald Hegen, Gerhard Traxler, et al.
European Journal of Neurology
|
December 28, 2020
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score
Gabriel Bsteh, Harald Hegen, Katharina Riedl, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
European Heart Journal. Case Reports
|
December 31, 2024
A rare cardiac presentation of a lymphoma: case report
Ilona Grohs, Katharina Riedl, Christa Kliment, et al.
Multiple Sclerosis and Related Disorders
|
May 31, 2022
Has the pandemic changed treatment strategy in multiple sclerosis?
Gabriel Bsteh, Katharina Riedl, Nik Krajnc, et al.
Frontiers in Neurology
|
March 24, 2022
Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
Nik Krajnc, Patrick Altmann, Katharina Riedl, et al.
Frontiers in Neurology
|
February 3, 2022
Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score
Gabriel Bsteh, Harald Hegen, Katharina Riedl, et al.
Multiple Sclerosis and Related Disorders
|
April 27, 2022
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication - a retrospective multicentre study
Franziska Di Pauli, Katharina Riedl, Harald Hegen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 2, 2022
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis
Klaus Berek, Harald Hegen, Jakob Hocher, et al.
Neurology
|
August 2, 2022
Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis
Gabriel Bsteh, Nik Krajnc, Katharina Riedl, et al.
European Journal of Neurology
|
November 27, 2024
Autoimmune screening panel in patients with multiple sclerosis: A Vienna multiple sclerosis database study
Fabian Föttinger, Nik Krajnc, Katharina Riedl, et al.
Multiple Sclerosis and Related Disorders
|
July 7, 2022
Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study
Nik Krajnc, Harald Hegen, Gerhard Traxler, et al.
European Journal of Neurology
|
December 28, 2020
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score
Gabriel Bsteh, Harald Hegen, Katharina Riedl, et al.
Page
of 2